Kevin Bitterman, Director, 10% Owner at Editas Medicine, Inc. (EDIT), sold 75,000 shares at $15.82 ($1.2M) on 2016-12-07, disclosed to the SEC on 2016-12-08.
Open-market sale of $1.2M EDIT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2026-09-03 | $4.4M | — | Filing → |
| IRON | SELL | 2025-12-18 | $69K | — | Filing → |
| IRON | SELL | 2025-12-16 | $33.1M | — | Filing → |